Niigata University granted Shimojani an exclusive, worldwide license to develop and commercialize technology from the university to reduce the risk of hemorrhage in acute ischemic stroke patients

Niigata University

Japan / Academic

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Shimojani LLC

U.S. / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced